Investment Pitches

Pitch Summary:
Shares of Alphabet, the parent company of Google and YouTube, were strong during the quarter on the successful rollout of its large language model Gemini 3. Market enthusiasm remains strong for Alphabet’s full-stack AI solution, encompassing research, infrastructure/data centers and integrated end products. With a valuation that is still reasonable, in our view, the company continues to share its ample store of cash with investors through buybacks and quarterly dividends. The company benefited from renewed confidence that it can compete at the frontier of generative AI. We continue to view Alphabet as a durable compounder with strong balance sheet flexibility.

BSD Analysis:
Alphabet remains a cash machine, but AI has turned monetization into an engineering problem instead of a given. Search dominance holds, yet answer-based interfaces threaten ad density over time. The real moat is distribution—Chrome, Android, YouTube, defaults—not model rankings. Cloud diversifies revenue but raises capital intensity and margin volatility. Regulation acts as a slow, structural tax on valuation. Buybacks support optics, not strategy. Optionality exists across YouTube, AI tools, and platforms, but monetization is uneven. The bull case is AI layered onto unmatched scale without cannibalization. Alphabet wins only if it evolves without breaking the engine that funds everything else.

Pitch Summary:
Unilever develops and markets everyday food and personal care brands for billions of consumers worldwide. Anchored by iconic brands such as Dove, Knorr, Hellmann’s and Vaseline, the company’s refreshed management team is driving improved execution and strategic discipline, focusing on higher-margin categories. Cost-savings initiatives and brand divestments are expected to unlock sustained value. Despite this outlook, the stock trades at a discount to peers due to a history of underperformance, creating an opportunity to invest ahead of improved per-share growth.

BSD Analysis:
Unilever is a global consumer giant fighting the gravity of its own size. The brand portfolio is powerful, but execution has been uneven across categories and geographies. Emerging markets provide growth, but also volatility and complexity. Pricing power has proven real, even if volumes wobble. Cost discipline matters more here than grand strategic reinventions. Divestitures and portfolio pruning are steps in the right direction. This is not a fast-growth consumer story. It’s a margin, mix, and execution story. Unilever works when management keeps things simple and stops overthinking the obvious.

Pitch Summary:
Symrise is a global leader in flavors, fragrances, and specialty ingredients. We value its leading positions in pet food palatability, beverage flavors and personal care ingredients, supported by a broad portfolio and long-standing customer relationships. These ingredients represent a small share of customers’ cost of goods sold but are critical to product performance, creating sticky relationships. Management’s renewed focus on profitability and cash flow shows early signs of operational inflection, while recent underperformance has created an attractive entry point.

BSD Analysis:
Symrise operates in the invisible layer of consumer products — flavors, fragrances, and ingredients people experience but never see. Customer relationships are sticky because formulations are hard to change without risking brand consistency. Pricing power exists, but it’s negotiated patiently rather than imposed. End markets like food, personal care, and pet nutrition provide defensive demand. Input cost inflation creates margin noise, not structural damage. Innovation is incremental and customer-led, which keeps failure rates low. Growth isn’t flashy, but returns are consistent. This is not a consumer brand. It’s sensory infrastructure with quiet durability.

Pitch Summary:
Sanofi is a global pharmaceutical company developing biologics, vaccines and healthcare solutions across immunology, hemophilia, rare diseases and general medicine. Management has prioritized innovation through aggressive R&D investment to build a promising pipeline. Despite strong fundamentals, the stock has been weighed down by vaccine market volatility and concerns about patent cliffs, with minimal value ascribed to the pipeline. This has created an opportunity to invest in a company with improving fundamentals and a long runway for growth as markets normalize and new products emerge.

BSD Analysis:
Sanofi is a pharma company in the middle of a necessary identity shift. Legacy franchises still throw off cash, but growth now depends on immunology and specialty care executing properly. Dupixent has proven Sanofi can deliver real innovation, not just manage decline. The pipeline is more focused than in the past, which reduces wasted R&D spend. Pricing pressure and patent cycles remain facts of life. Capital allocation has improved, favoring discipline over empire-building. This is not a high-momentum pharma story. It’s a credibility rebuild with upside if execution sticks. Sanofi wins by doing fewer things better.

Pitch Summary:
AstraZeneca is one of the largest pharmaceutical companies in the world. It researches, develops and commercializes prescription medicines designed to treat lung and breast cancers, cardiorenal diseases, respiratory problems and other rare diseases. We believe AstraZeneca's robust on-market portfolio and sector-leading late-stage pipeline provide an attractive growth profile. Moreover, we believe the company can build on its long track record of a productive research and development program, thanks to its innovative culture and exceptional management team. Recent concerns over United States regulations have overshadowed AstraZeneca’s merits and weighed on the broader pharmaceutical industry, opening a window to purchase shares well below intrinsic value.

BSD Analysis:
AstraZeneca has rebuilt its pipeline into one of the strongest in global pharma. Oncology and rare disease franchises drive durable growth beyond pandemic optics. Geographic diversification reduces single-market risk. Investors worry about patent cliffs and miss pipeline depth. Manufacturing scale supports rapid launch execution. Capital allocation balances R&D and returns effectively. This is big pharma executing with momentum rather than defending legacy.

Pitch Summary:
Dassault Systèmes was a detractor during the quarter. The France-headquartered application software company’s stock price declined as it reported disappointing third-quarter results. Revenues came in at the low end of the guidance range, and full-year organic growth projections were decreased. The shortcomings can largely be attributed to the Life Sciences and Mainstream Innovation segments, where growth was challenged. Still, Dassault Systèmes is a relatively new holding for us, and we continue to see it as a high-quality software business with attractive upside.

BSD Analysis:
Dassault owns mission-critical design software embedded in aerospace, automotive, and industrial workflows. Switching costs are existential once digital twins and product lifecycles are built around the platform. Growth looks steady rather than explosive, but margins reflect monopoly-like positioning. Investors underappreciate how deeply regulated industries rely on Dassault. Cloud migration improves visibility without weakening lock-in. This is engineering infrastructure monetizing complexity. You don’t rip out CAD systems.

Pitch Summary:
CNH Industrial was a detractor during the quarter. The agricultural and farm equipment company’s stock price declined as it released underwhelming results and reduced earnings-per-share guidance. Management cited challenges with the business mix, tariffs, and destocking pressures as the primary reasons for the shortcomings. We met with the CEO and believe these headwinds should subside in the coming periods as the environment turns favorable. In our view, there is a long runway for future growth as the company realizes the benefits of its renewed focus on performance-oriented culture, procurement, quality costs, and other initiatives.

BSD Analysis:
CNH is agricultural and construction equipment tied to food security and infrastructure, not consumer fashion. Farm economics drive demand more than GDP cycles. Precision ag and autonomy improve mix and margins over time. Investors focus on equipment cyclicality and miss recurring aftermarket and software revenue. Scale matters in dealer networks and parts logistics. Capital allocation has sharpened post-separation. This is machinery tied to necessity, not optional spend.

Pitch Summary:
Alibaba Group was a detractor during the quarter. The China-headquartered technology conglomerate’s stock price declined as it reported mixed results. The core E-commerce business continues to perform well, and Cloud revenue growth is accelerating. However, the company’s earnings were negatively impacted due to significant spending on subsidies to grow their Quick Commerce business, in our opinion. We believe losses from Quick Commerce will be reduced over time and continue to believe the company is well-positioned for long-term growth, having been one of the early investors in Chinese AI. Over time, we think it can leverage its advanced capabilities and leading market position to unlock further value.

BSD Analysis:
Alibaba remains core infrastructure for Chinese commerce, cloud, and logistics despite regulatory scars. Investors price in permanent impairment while cash flow keeps coming. E-commerce profitability matters more than headline GMV. Cloud normalization masks long-term relevance as digitization continues. Capital discipline has improved after forced restructuring. Share buybacks quietly return value. This is platform dominance priced like a governance problem.

Pitch Summary:
Samsung Electronics was a contributor during the quarter. The South Korea-headquartered tech company’s stock price rose as earnings staged a sharp recovery due to strength in its core semiconductor business. We recently met with the company in Korea and were reassured by its confidence in its High Bandwidth Memory product lineup, which has continued to improve under new management. We continue to believe Samsung is one of the world’s leading semiconductor companies with a long runway for future growth.

BSD Analysis:
Samsung is one of the few companies that can manufacture at global scale across memory, logic, displays, and consumer electronics. Cyclicality dominates the narrative, but vertical integration creates leverage when the cycle turns. Memory downturns hurt earnings optics while strengthening competitive position. Investors fixate on near-term pricing and miss replacement demand tied to AI and data growth. Capital intensity is high, but scale keeps Samsung relevant across nodes others can’t afford. Balance sheet strength provides patience. This is industrial-scale technology that survives every cycle.

Pitch Summary:
DSV was a contributor during the quarter. The Denmark-headquartered air freight and logistics company’s stock price rose as it delivered what we view as solid third-quarter results. DSV is accelerating the timeline for the realization of synergies from its DB Schenker acquisition, which management attributed to having more detailed plans and reducing uncertainties around the integration. We continue to think freight forwarding is a high-growth, return-generative business that benefits from an asset-lite model. In our view, DSV has the industry’s best management team, which has the company well-positioned for future growth and to expand its already industry-leading profitability.

BSD Analysis:
DSV’s moat is execution discipline at scale in a notoriously unforgiving industry. Customers value reliability over price when disruptions are costly. Asset-light structure provides flexibility, but global trade cycles still dominate earnings. M&A is the growth engine, and integration skill is the differentiator. Margins compress fast when volumes slow despite variable-cost narratives. The bull case is continued consolidation with DSV as the natural acquirer. The bear case is prolonged trade weakness exposing operating leverage. DSV compounds by being relentlessly competent where others aren’t.

Pitch Summary:
Bayer was a contributor during the quarter. Two anticipated events developed in the company’s favor. First, Bayer enjoyed a positive readout on the company’s stroke drug, Asundexian, which met its primary endpoint in a recent phase III trial. Asundexian has the potential to be a blockbuster and support a return to growth for the Pharmaceuticals business, in our opinion. Second, the United States Solicitor General recommended that the Supreme Court hear Bayer’s appeal in Durnell v. Monsanto, increasing the odds that the RoundUp matter is heard by the Court. Both events support our investment thesis for Bayer as management works to turn around fundamental performance and contain litigation risk.

BSD Analysis:
Bayer’s moat is scientific breadth across pharma, crop science, and consumer health—but complexity dilutes returns. Litigation overhang from Monsanto continues to cap valuation regardless of operating performance. Pharma innovation competes for capital with cyclical ag exposure. Pricing power exists in pockets, but regulation constrains realization. Balance-sheet repair limits strategic flexibility. Execution risk is elevated because management must fix multiple problems at once. The bull case is litigation resolution and focused capital allocation. The bear case is ongoing legal drag and earnings volatility. Bayer is optionality-heavy with patience required.

Pitch Summary:
Targa Resources is a leading midstream natural gas and natural gas liquids (NGL) company. Targa is part of a group that controls 90% of the fractionation capacity in the largest hub for NGLs in the world, known as Mont Belvieu. Thanks to the region's unique topography and proximity to the Gulf Coast, Targa benefits from meaningful cost advantages and significant barriers to entry. We like that Targa generates approximately 90% of its earnings through multiyear fee-based arrangements with its customer base, which provides protection against oversupply or re-contracting. Uncertainty around Permian oil production growth has recently weighed on the share price. However, in our view, Targa remains well-positioned to grow, even if the Permian slows dramatically. We were happy to purchase shares at a discount to peers based on normalized earnings power and our estimate of intrinsic value.

BSD Analysis:
Targa’s moat is irreplaceable midstream assets tied to U.S. NGL and gas growth basins. Volume-based contracts smooth revenue, but commodity cycles still leak through indirectly. Capital intensity makes balance-sheet discipline essential. Pricing power comes from connectivity and location, not negotiation leverage. Growth depends on producer activity staying rational. Operating leverage rewards scale during upcycles. The bull case is sustained U.S. gas/NGL throughput with capital returns. The bear case is basin slowdown or regulatory friction. Targa works as infrastructure income with cyclical undertones.

Pitch Summary:
Liberty Broadband was a detractor during the quarter. The U.S.-headquartered cable and satellite company’s stock price declined as it is merging with Charter Communication in 2026 and its share-price now trades similarly to the Charter share-price. Charter reported weak earnings at the end of October. Broadband subscriber numbers and adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) declined. Still, management is guiding to flat full-year EBITDA. Positively, broadband average revenue per user, free cash flow, and capital returns were strong.

BSD Analysis:
Liberty Broadband is effectively a leveraged bet on Charter, wrapped in holding-company structure. The moat is cable infrastructure economics—high fixed costs that deter competition. Capital allocation and leverage amplify outcomes more than operations do. Discounts to NAV persist because control and realization are optional. Broadband demand is stable, but pricing power faces regulatory and competitive pressure from fiber. Buybacks can create value, but timing matters. The bull case is steady cash flow plus multiple expansion at Charter. The bear case is structural broadband competition compressing returns. Liberty Broadband rewards patience and tolerance for opacity.

Pitch Summary:
Paycom Software was a detractor during the quarter. The U.S.-headquartered human resources and employment services company’s stock price declined alongside peers due to broad underperformance in the application software sector. We continue to believe Paycom has a long runway for future growth and that system-of-record software companies like Paycom will not be replaced by AI. We appreciate management’s focus on ramping share repurchases, which we believe will add significant per-share value at today’s stock price.

BSD Analysis:
Paycom’s moat is single-database HCM architecture that reduces reconciliation pain for mid-sized employers. Once payroll, time, and benefits live in one system, switching becomes operationally risky. Growth has slowed as penetration deepens, exposing how much upside was front-loaded. Pricing power exists, but customers are cost-sensitive when hiring cools. Product-led automation differentiates Paycom, yet competitors are closing feature gaps. Sales efficiency matters more now than logo growth. The bull case is renewed hiring cycles and upsell of automation tools. The bear case is saturation revealing a narrower TAM. Paycom compounds only if product advantage keeps outpacing commoditization.

Pitch Summary:
Equifax was a detractor during the quarter. The U.S.-headquartered credit bureau's stock price slid despite posting results where revenues, earnings before interest, tax, depreciation, and amortization, and earnings per share all outperformed consensus expectations. Still, FICO's new Mortgage Direct License Program has investors concerned that resellers will be able to bypass credit bureaus while still accessing scores, leading to markups dissolving. In our view, Equifax's updated pricing has the potential to alleviate most concerns associated with the FICO announcement. We met with management and continue to believe the stock is a very attractive investment.

BSD Analysis:
Equifax is a data monopoly hiding behind a permanently damaged reputation. Credit data is not optional — lenders, employers, and governments still need it regardless of headlines. The post-breach rebuild forced modernization that ultimately strengthened the platform. Pricing power exists because alternatives lack comparable breadth and history. Revenue is recurring and embedded across financial workflows. Regulatory scrutiny is constant, but barriers to entry are enormous. Growth is steady rather than exciting, which is exactly the point. This is not a fintech disruptor. It’s data infrastructure with scar tissue and durability.

Pitch Summary:
First Citizens Bancshares was a contributor during the quarter. The U.S.-headquartered diversified bank’s stock price rose after it delivered solid results, with earnings per share exceeding consensus expectations. Loans and Deposits grew healthily, and management continues to repurchase stock at a steady pace. We continue to believe that First Citizens is a high-quality regional bank with a strong management team that we think can help it unlock sustained long-term value.

BSD Analysis:
First Citizens is a quietly exceptional bank built on conservative underwriting and opportunistic deal-making. The Silicon Valley Bank asset acquisition was a once-in-a-cycle move that materially reset earnings power. Management has a long track record of patience rather than growth-at-any-cost behavior. Credit quality has historically been strong because risk appetite is cultural. Net interest margins will normalize, but the asset base is structurally stronger now. Capital levels support flexibility without forcing dilution. This is not a flashy regional bank. It’s a disciplined allocator wearing a plain wrapper. When panic creates opportunity, First Citizens tends to win.

Pitch Summary:
Alphabet was a contributor during the quarter. The U.S.-headquartered technology conglomerate’s stock price jumped after it delivered impressive third-quarter earnings. Search revenue growth beat consensus expectations as Google continues to see strong user engagement trends. Results were also ahead of expectations in the Cloud segment, and the outlook for this business remains robust given accelerating demand for AI compute. We continue to believe Alphabet is undervalued on a sum-of-the-parts basis and see potential for the company’s AI leadership to drive further upside across the portfolio.

BSD Analysis:
What investors miss about Alphabet is that its biggest risk is also its biggest strength: sheer scale. Disruption narratives underestimate how deeply Google is embedded in daily behavior and enterprise workflows. AI doesn’t eliminate search — it changes how queries are answered and monetized. YouTube is quietly becoming the most powerful video platform on earth, not just an ad business. Cloud growth doesn’t need to win the market to move earnings meaningfully. Regulatory overhang suppresses the multiple, not the cash flow. Capital returns are now a real part of the story. This is not a story stock anymore. It’s a dominant platform trading below its strategic value.

Pitch Summary:
Warner Bros Discovery (WBD) was a contributor during the quarter. The U.S.-headquartered media company’s stock price surged as multiple parties submitted offers to acquire all or part of the business. Following several rounds of bidding, WBD announced an agreement to sell its Streaming and Studios business to Netflix, while spinning the Global Networks business to shareholders. Paramount Skydance subsequently made a direct $30 per share offer to shareholders for the entire company. We are pleased with the steps the WBD board has taken thus far to unlock shareholder value. We will continue to closely monitor developments as this bidding war unfolds.

BSD Analysis:
Warner Bros. Discovery is a content empire weighed down by leverage, complexity, and execution risk. The assets are real — HBO, Warner Bros., DC — but monetization has been uneven and strategy has shifted too often. Streaming losses have narrowed, yet the business still lacks a clean growth narrative. Linear TV decline continues to pressure cash flow optics. Debt constrains flexibility and magnifies mistakes. Cost-cutting helps margins but can’t replace demand growth forever. This is not a quality compounder. It’s a balance-sheet and execution turnaround. The upside exists only if management finally picks a lane and sticks to it.

Pitch Summary:
Alphabet Class C, an underweight position, was one of the top performers in the period. Share price performance was driven by robust advertising revenue growth. YouTube and Search benefited from a rebound in digital advertising during the holiday season. Cloud revenues saw double-digit growth and margin improvement. Cost optimization initiatives boosted profitability, leading to positive investor sentiment.

BSD Analysis:
Alphabet remains one of the most dominant cash-flow machines ever created, despite trading like it’s permanently under siege. Search is still default behavior for billions, and AI enhances monetization rather than destroying it. YouTube has matured into a multi-engine business spanning ads, subscriptions, and creator monetization. Google Cloud is no longer a science project — profitability changes the earnings profile materially. Regulatory pressure is constant, but user behavior hasn’t meaningfully shifted. Capital discipline has improved through buybacks and cost control. The balance sheet provides absurd optionality for AI investment. This is not a melting ice cube. It’s a tollbooth adapting faster than critics admit.

Pitch Summary:
Zoetis is held due to its attractive sustainability opportunity profile and strong governance. During the quarter, there was disappointment in the company’s Q3 earnings update. While Zoetis has a full pipeline of new products to launch, there is some time before these can materially accelerate revenue growth. The company faces increasing competition across some established franchises. Its key canine arthritis pain product Librela declined more than expected due to side-effect perception issues.

BSD Analysis:
Zoetis dominates animal health with a portfolio that benefits from rising pet humanization and global protein demand. Veterinary care is less price-sensitive than human healthcare, supporting margins. Recurring treatments and diagnostics drive stable revenue. Investors worry about growth normalization and miss the durability of demand. R&D and commercial scale create real barriers to entry. International expansion extends the runway. This is healthcare economics applied to animals, and it compounds quietly.